Use of the Triage Stroke Panel in a neurologic emergency service

American Journal of Emergency Medicine

Volumn 27, Issue 5, 2009, Pages 558-562

  Sibon, Igor ^a   Rouanet, François ^a   Meissner, Wassilios ^a   Orgogozo, Jean Marc ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; D DIMER; GELATINASE B; PROTEIN S100B;

AGED; ARTICLE; BLOOD ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; NURSING STAFF; POINT OF CARE TESTING; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY AND SPECIFICITY; STROKE; TRANSIENT ISCHEMIC ATTACK;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; NATRIURETIC PEPTIDE, BRAIN; NERVE GROWTH FACTORS; NURSING ASSESSMENT; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; STROKE; TRIAGE;

EID: 66049159080     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.05.001     Document Type: Article

References (35)

1. Citerio G., Galli D., Cadore B., et al. How to improve ischemic stroke treatment in the fibrinolysis era. Minerva Anestesiol 72 (2006) 407-412
2. Hacke W., Brott T., Caplan L., et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 53 (1999) S3-S14
3. Wardlaw J.M., Zoppo G., Yamaguchi T., et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev (2003) CD000213
4. Kwan J., Hand P., and Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age Ageing 33 (2004) 116-121
5. Kwan J., Hand P., and Sandercock P. Improving the efficiency of delivery of thrombolysis for acute stroke: a systematic review. QJM 97 (2004) 273-279
6. Alberts M.J., Perry A., Dawson D.V., et al. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 23 (1992) 352-356
7. Morgenstern L.B., Staub L., Chan W., et al. Improving delivery of acute stroke therapy: the TLL Temple Foundation Stroke Project. Stroke 33 (2002) 160-166
8. Sandercock P., Berge E., Dennis M., et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess 6 (2002) 1-112
9. Bray J.E., Martin J., Cooper G., et al. An interventional study to improve paramedic diagnosis of stroke. Prehosp Emerg Care 9 (2005) 297-302
10. Bray J.E., Martin J., Cooper G., et al. Paramedic identification of stroke: community validation of the Melbourne ambulance stroke screen. Cerebrovasc Dis 20 (2005) 28-33
11. Rosamond W., Flegal K., and Friday G. Heart disease and stroke statistics-2007 update (2007). http://circahajournalsorg/cgi/content/full/115/5/e69#TBL5179743
12. Katzan I.L., Furlan A.J., Lloyd L.E., et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283 (2000) 1151-1158
13. Wang D.Z., Rose J.A., Honings D.S., et al. Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke 31 (2000) 77-81
14. Mehdiratta M., Woolfenden A.R., Chapman K.M., et al. Reduction in IV t-PA door to needle times using an Acute Stroke Triage Pathway. Can J Neurol Sci 33 (2006) 214-216
15. Lindsberg P.J., Happola O., Kallela M., et al. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology 67 (2006) 334-336
16. Ornstein S.M. Translating research into practice using electronic medical records the PPRNet-TRIP project: primary and secondary prevention of coronary heart disease and stroke. Top Health Inf Manage 22 (2001) 52-58
17. Brous E. A patient with an undetected evolving stroke: legal lessons learned. J Emerg Nurs 31 (2005) 580-582
18. Laskowitz D. A point of care diagnostic for acute stroke. 14th Annual European Stroke Conference, Bologna, Italy (2005)
19. Kim J.S., Yoon S.S., Kim Y.H., et al. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 27 (1996) 1553-1557
20. Dziedzic T., Bartus S., Klimkowicz A., et al. Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood. Stroke 33 (2002) 2334-2335
21. Montaner J., Alvarez-Sabin J., Molina C., et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 32 (2001) 1759-1766
22. Perini F., Morra M., Alecci M., Galloni E., et al. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci 22 (2001) 289-296
23. Vila N., Castillo J., Davalos A., and Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31 (2000) 2325-2329
24. Fon E.A., Mackey A., Cote R., et al. Hemostatic markers in acute transient ischemic attacks. Stroke 25 (1994) 282-286
25. Takano K., Yamaguchi T., and Uchida K. Markers of a hypercoagulable state following acute ischemic stroke. Stroke 23 (1992) 194-198
26. Buttner T., Weyers S., Postert T., et al. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 28 (1997) 1961-1965
27. Martens P., Raabe A., and Johnsson P. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 29 (1998) 2363-2366
28. Tarkowski E., Rosengren L., Blomstrand C., et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26 (1995) 1393-1398
29. Fassbender K., Rossol S., Kammer T., et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 122 (1994) 135-139
30. Lynch J.R., Blessing R., White W.D., et al. Novel diagnostic test for acute stroke. Stroke 35 (2004) 57-63
31. Jauch E.C., Lindsell C., Broderick J., et al. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator stroke study. Stroke 37 (2006) 2508-2513
32. Rainer T.H., Lam N.Y., Man C.Y., et al. Plasma beta-globin DNA as a prognostic marker in chest pain patients. Clin Chim Acta 368 (2006) 110-113
33. Dambinova S.A., Khounteev G.A., and Skoromets A.A. Multiple panel of biomarkers for TIA/stroke evaluation. Stroke 33 (2002) 1181-1182
34. Reynolds M.A., Kirchick H.J., Dahlen J.R., et al. Early biomarkers of stroke. Clin Chem 49 (2003) 1733-1739
35. Grifoni S., Vanni S., Caini R., et al. Biochemical markers for the diagnosis of stroke: do they work in the real world. Conferenza nationale dell ictus cerebrale, Firenze, Italy (2006)